论文部分内容阅读
本文对１９例口腔颌面部良性肿瘤，２２例恶性肿瘤（术前和术后２周），８例复发性恶性肿瘤，１８例无复发恶性肿瘤和２０名正常健康人作血清可溶性白细胞介素－２受体检测．结果良性肿瘤组和无复发组与正常人无显著性差异（ｐ＜０．０５），恶性肿瘤术前和术后２周以及复发组与正常人或良性肿瘤组有非常显著性差异（ｐ＜０．０１）．表明ＳＩＬ－２Ｒ水平检测在临床上对口腔颌面部肿瘤的诊断，治疗过程免疫功能监测和病者预后估测均有较高价值．
In this paper, 19 cases of oral and maxillofacial benign tumor, 22 cases of malignant tumor (preoperative and postoperative 2 weeks), 8 cases of recurrent malignant tumor, 18 cases of recurrent malignant tumor and 20 normal healthy people as serum soluble interleukin -2 receptor test. Results There was no significant difference between benign tumor group and non-recurrence group (p <0.05), preoperative and postoperative 2 weeks, recurrence group and normal or benign tumor (p < 0.01). It is indicated that the detection of SIL-2R level in clinical diagnosis of oral and maxillofacial tumors, immune function monitoring during treatment and prognosis of patients have high value.